Congratulations to Quanxin Biotech on the approval and authorization of the sixt
Recently, Jiangsu Qyuns Therapeutics Co., Ltd. obtained grant authorization in Australia for its patent application corresponding to the family of “Anti-Human Interleukin-4 Receptor Alpha Monoclonal Antibody and Use Thereof” (Australian title ...

